Doximity, Inc. (NASDAQ:DOCS) Given Average Rating of "Moderate Buy" by Analysts

Key Points

• Doximity, Inc. has received a consensus rating of "Moderate Buy" from twenty-three research firms, with an average price target of $66.21 over the next year.
• The company reported an earnings per share (EPS) of $0.36 for the latest quarter, surpassing the consensus estimate of $0.31, indicating a positive financial trajectory.
• Insider trading activity has seen a total of 32,000 shares sold recently, signaling potential shifts in ownership and insider sentiment regarding the stock's future performance.

Shares of Doximity, Inc. (NASDAQ:DOCS - Get Free Report) have been given a consensus rating of "Moderate Buy" by the twenty-three brokerages that are presently covering the firm, Marketbeat Ratings reports. Eleven analysts have rated the stock with a hold rating, ten have given a buy rating and two have assigned a strong buy rating to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $66.2105.

Several equities analysts recently issued reports on the company. Canaccord Genuity Group boosted their price target on Doximity from $50.00 to $59.00 and gave the company a "hold" rating in a research note on Friday, August 8th. Needham & Company LLC boosted their price target on Doximity from $67.00 to $75.00 and gave the company a "buy" rating in a research note on Friday, August 8th. William Blair restated an "outperform" rating on shares of Doximity in a research note on Friday, May 16th. KeyCorp boosted their price target on Doximity from $65.00 to $70.00 and gave the company an "overweight" rating in a research note on Monday, July 14th. Finally, Zacks Research lowered Doximity from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, August 20th.

Doximity Stock Performance

Shares of Doximity stock traded up $0.79 during trading on Wednesday, reaching $69.31. The company's stock had a trading volume of 787,369 shares, compared to its average volume of 2,255,650. The business's fifty day moving average price is $62.50 and its 200-day moving average price is $60.11. The firm has a market cap of $12.98 billion, a price-to-earnings ratio of 69.31, a price-to-earnings-growth ratio of 4.10 and a beta of 1.37. Doximity has a one year low of $35.32 and a one year high of $85.21.

Doximity (NASDAQ:DOCS - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.36 EPS for the quarter, topping analysts' consensus estimates of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.The firm's quarterly revenue was up 15.2% on a year-over-year basis. During the same period last year, the firm earned $0.28 EPS. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Sell-side analysts anticipate that Doximity will post 0.99 EPS for the current year.

Insider Buying and Selling at Doximity

In other Doximity news, Director Kira Scherer Wampler sold 2,000 shares of Doximity stock in a transaction that occurred on Friday, August 1st. The stock was sold at an average price of $57.09, for a total transaction of $114,180.00. Following the sale, the director directly owned 16,618 shares of the company's stock, valued at approximately $948,721.62. The trade was a 10.74% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Timothy S. Cabral sold 10,000 shares of Doximity stock in a transaction that occurred on Wednesday, June 25th. The shares were sold at an average price of $60.00, for a total value of $600,000.00. Following the sale, the director directly owned 6,360 shares in the company, valued at $381,600. The trade was a 61.12% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 32,000 shares of company stock valued at $1,929,380. 31.30% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of DOCS. SG Americas Securities LLC acquired a new position in Doximity during the 1st quarter worth $65,702,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in shares of Doximity by 130.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,966,801 shares of the company's stock valued at $114,133,000 after acquiring an additional 1,113,076 shares during the last quarter. Franklin Resources Inc. raised its position in shares of Doximity by 53.9% during the 2nd quarter. Franklin Resources Inc. now owns 3,162,593 shares of the company's stock valued at $193,993,000 after acquiring an additional 1,108,162 shares during the last quarter. Vanguard Group Inc. raised its position in shares of Doximity by 8.8% during the 1st quarter. Vanguard Group Inc. now owns 12,194,492 shares of the company's stock valued at $707,646,000 after acquiring an additional 990,923 shares during the last quarter. Finally, Holocene Advisors LP bought a new stake in shares of Doximity during the 2nd quarter valued at $44,983,000. Institutional investors and hedge funds own 87.19% of the company's stock.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.